Global Atosiban Market: Introduction

Atosiban is a combined oxytocin or vasopressin V1A antagonist. Oxytocin causes uterine contractions and helps in preterm labor. The total atosiban dose should not exceed 330 mg for an individual. Several clinical trials have been carried out to determine the efficacy and the safety of Atosiban. For instance, Atosiban versus placebo, Atosiban versus beta-mimetics, and Atosiban versus nifedipine.  Currently, no side-effects have been reported. Atosiban is licenced for use as a tocolytic.

 Request Brochure for Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=81975

Key Drivers of Global Atosiban Market 

Prevalence of autism

According to The Centers for Disease Control and Prevention (CDC), autism prevalence increases by nearly 10% to 1 in 54 children in the U.S. In 2016, 1 in 54 children had a diagnosis of ASD by age 8, a 10% increase over 2014 when the estimate was 1 in 59.

According to The Autism Society of America, among boys aged eight years, the prevalence was 29.7 per 1,000, 4.3 times higher than the 6.9 per 1,000 prevalence among girls aged eight years. According to WHO-World Health Organization, it is estimated that worldwide one in 160 children has an Autism spectrum disorder-ASD.

 Request for Analysis of COVID19 Impact on Atosiban Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=81975

Rise in preterm labor complications

According to WHO-World Health Organization, an estimate of 15 million babies are born preterm every year, and the number continues to rise. Preterm birth complications are the leading cause of death among children under 5 years of age, responsible for approximately 1 million deaths in 2015, i.e., 1 in 10 babies. Approximately 1 million children die each year due to complications of preterm birth. More than 60% of preterm births occur in Africa and South Asia; however, preterm birth is a truly global issue. 90% of extremely preterm born in low-income countries die within the first few days of life, and less than 10% of extremely preterm babies die in high-income settings. WHO is conducting two clinical trials, called the WHO ACTION Trials (Antenatal Corticosteroids for Improving Outcomes in preterm Newborns) for women at risk of preterm birth. According to Save the Children Federation, Inc., preterm birth is a leading cause of under-5 mortality, taking nearly 1 million lives every year, with the rate of preterm birth increasing in several countries.

Pre book Market Report –

https://www.transparencymarketresearch.com/checkout.php?rep_id=81975&ltype=S

North America to Account for Major Share of Global Atosiban Market 

  • North America is projected to account for a major share of the global Atosiban market during the forecast period. The market in the region is anticipated to expand at a rapid pace in the next few years due to an increase in research & development and technologically advanced products being introduced in the market. Europe is expected to be the second-largest market during the forecast period owing to advanced facilities provided by the hospital infrastructure in the region.
  • The Atosiban Market in Asia Pacific is likely to expand at a high CAGR during the forecast period owing to the dense population and high birthrate in the region

 Ask for Discount :

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=81975

Key Players Operating in Global Atosiban Market 

The global Atosiban market is highly consolidated owing to the presence of several key players. Leading players operating in the global Atosiban market include:

  • Ferring Pharmaceuticals
  • Sun Pharma
  • Shanghai Soho-Yiming Pharmaceuticals
  • EVER Pharma
  • Hangzhou Longshine Bio-Tech
  • Cayman Chemical
  • Neore Pharmaceutical

Browse more Market Reports:

High Potency Active Pharmaceutical Ingredient Market:

https://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html

Bioremediation Technology & Services Market:

https://www.transparencymarketresearch.com/bioremediation-technology-services-market.html

Endocrine Testing Market:

https://www.transparencymarketresearch.com/endocrine-testing-market.html

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

LEAVE A REPLY

Please enter your comment!
Please enter your name here